These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 36246627)

  • 21. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs.
    Zhang L; Tang X; Wan J; Zhang X; Zheng T; Lin Z; Liu T
    Front Mol Biosci; 2021; 8():715764. PubMed ID: 34733885
    [No Abstract]   [Full Text] [Related]  

  • 22. N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer.
    Zhang H; Zhao L; Li S; Wang J; Feng C; Li T; Du X
    Front Oncol; 2021; 11():697949. PubMed ID: 34178697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer.
    Yu L; Wang L; Sun J; Zhou X; Hu Y; Hu L; He Y; Lin C; Chen J; Xu X; Dunlop MG; Theodoratou E; Ding K; Li X
    Front Genet; 2023; 14():885930. PubMed ID: 36936424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
    Liu Y; Wang T; Fang Z; Kong J; Liu J
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer.
    Feng ZH; Liang YP; Cen JJ; Yao HH; Lin HS; Li JY; Liang H; Wang Z; Deng Q; Cao JZ; Huang Y; Wei JH; Luo JH; Chen W; Chen ZH
    J Transl Med; 2022 Oct; 20(1):492. PubMed ID: 36309694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated Analysis of the Immune Infiltrates and PD-L1 Expression of N6-Methyladenosine-Related Long Non-Coding RNAs in Colorectal Cancer.
    Jiang Z; Zhang Y; Chen K; Yang X; Liu J
    Int J Gen Med; 2021; 14():5017-5028. PubMed ID: 34511985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Validation of a Novel 2-LncRNAs Signature Associated with m6A Regulation in Colorectal Cancer.
    Wang K; Zhao B; Liang Y; Ma B
    J Cancer; 2022; 13(1):21-33. PubMed ID: 34976168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-Talk Between m
    Song W; Ren J; Xiang R; Yuan W; Fu T
    Front Immunol; 2022; 13():740960. PubMed ID: 35350786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an m6A-related lncRNA prognostic signature in colorectal cancer.
    Shi ZL; Yang X; Shen CL; Zhou GQ
    J Biochem Mol Toxicol; 2023 Jan; 37(1):e23239. PubMed ID: 36205301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
    Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
    BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs.
    Zeng H; Xu Y; Xu S; Jin L; Shen Y; Rajan KC; Bhandari A; Xia E
    Front Cell Dev Biol; 2021; 9():698388. PubMed ID: 34490250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients.
    Zhang P; Liu G; Lu L
    Front Cell Dev Biol; 2021; 9():703629. PubMed ID: 34336856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment.
    Cao PW; Liu L; Li ZH; Cao F; Liu FB
    Front Genet; 2022; 13():853471. PubMed ID: 35547245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of m6A-Related lncRNAs Associated With Prognoses and Immune Responses in Acute Myeloid Leukemia.
    Li D; Liang J; Cheng C; Guo W; Li S; Song W; Song Z; Bai Y; Zhang Y; Wu X; Zhang W
    Front Cell Dev Biol; 2021; 9():770451. PubMed ID: 34869365
    [No Abstract]   [Full Text] [Related]  

  • 38. Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs.
    Wang Y; Zhang D; Li Y; Wu Y; Ma H; Jiang X; Fu L; Zhang G; Wang H; Liu X; Cai H
    Front Genet; 2023; 14():906346. PubMed ID: 37396046
    [No Abstract]   [Full Text] [Related]  

  • 39. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma.
    Zhang Z; Wang F; Zhang J; Zhan W; Zhang G; Li C; Zhang T; Yuan Q; Chen J; Guo M; Xu H; Yu F; Wang H; Wang X; Kong W
    Front Pharmacol; 2022; 13():854851. PubMed ID: 35431958
    [No Abstract]   [Full Text] [Related]  

  • 40. Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma.
    Wang Y; Ji Y; Xu Q; Huang W
    Front Genet; 2022; 13():866340. PubMed ID: 36226185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.